Theriva Biologics, Inc.
SEC CIK 894158 · TOVX · last insider filing 2026-01-06
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Monahan John J | Director | filed 2020 - 2026 |
| Shallcross Steven A | Director · Interim CEO and CFO | filed 2015 - 2026 |
| Kraws Jeffrey J | Director | filed 2006 - 2026 |
| Wolf Jeffrey Alan | Director | filed 2006 - 2026 |
| Tarriff Scott | Director | filed 2012 - 2020 |
| Riley Jeffrey Scott | Director · Chief Executive Officer | filed 2010 - 2016 |
| Kanzer Steve H | Director · Chief Executive Officer | filed 2006 - 2014 |
| Stacks Nelson K. | Director | filed 2012 - 2012 |
| KUO James S | Director · Chairman, CEO & President | filed 2007 - 2011 |
| Lyon Lyman Max Jr | Director · CEO & President | filed 2009 - 2009 |
| Stergis Nicholas | Director · Chief Executive Officer | filed 2006 - 2008 |
| Rudick A Joseph | Director | filed 2006 - 2008 |
| Dorman Daniel J | Director | filed 2007 - 2007 |
| Bisgaier Charles PhD | Director · President | filed 2006 - 2007 |
| Manion Michael F | Director · President | filed 2006 - 2006 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Tufaro Francis | Chief Operating Officer | filed 2022 - 2022 |
| Sliman Joseph A. | Chief Medical Officer | filed 2017 - 2017 |
| Ballantyne Charles Evan | Chief Financial Officer | filed 2012 - 2015 |
| Newsome David A. | Chief Scientific Officer | filed 2007 - 2007 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.